Recipharm closes deal on Indian injectables business

Recipharm acquires majority stake in Nitin Lifesciences (Nitin), an Indian sterile injectables CMO

Thomas Eldered, CEO of Recipharm said: “I am delighted that we have now completed this transaction. The combination of Nitin and Recipharm represents an important step in the development of both companies and I am pleased that both Dr Chetan Sobti and Nitin Sobti will be continuing in their current positions”.

Mr Sobti, founder of Nitin Lifesciences, commented “This partnership represents a real opportunity to take Nitin Lifesciences to a new level. The combination allows both organisations to access a wider customer base and to gain important learning from each other. The Sobti family is very pleased to be entering into this new strategic partnership which will be hugely beneficial for both companies”.